China NT Pharma Group Company Limited (1011.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 454.39M |
| Enterprise Value | 764M |
| P/E Ratio | -8.63 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 5.68 |
| Price/Book Ratio | -2.27 |
| Enterprise/Revenue | 14.78 |
| Enterprise/EBITDA | -39.76 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.77 |
| Operating Margin | -0.39 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 24.16M |
| Revenue/Share | 0.04 |
| Gross Profit | 9.61M |
| EBITDA | -12.32M |
| Net Income | -26.04M |
| Diluted EPS | -0.04 |
Balance Sheet
| Total Cash | 11.91M |
| Total Cash/Share | 0.01 |
| Total Debt | 334.93M |
| Total Debt/Equity | -3.01 |
| Current Ratio | 0.05 |
| Book Value Per Share | -0.06 |
Price History
| 52-Week Change | -67.27 |
| 52-Week High | 1.2 |
| 52-Week Low | 0.3 |
| Moving Average 50 Days | 0.38 |
| Moving Average 200 Days | 0.62 |
Statistics
| Average Volume | 257,762 |
| Shares Outstanding | 656.45M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 03, 2024 |
AD
